558 related articles for article (PubMed ID: 27001312)
1. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
[TBL] [Abstract][Full Text] [Related]
2. Glioma cancer stem cells induce immunosuppressive macrophages/microglia.
Wu A; Wei J; Kong LY; Wang Y; Priebe W; Qiao W; Sawaya R; Heimberger AB
Neuro Oncol; 2010 Nov; 12(11):1113-25. PubMed ID: 20667896
[TBL] [Abstract][Full Text] [Related]
3. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.
Chen X; Wang L; Wang W; Zhao L; Shan B
Cancer Sci; 2016 Jul; 107(7):944-54. PubMed ID: 27088889
[TBL] [Abstract][Full Text] [Related]
4. B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells.
Yao Y; Wang X; Jin K; Zhu J; Wang Y; Xiong S; Mao Y; Zhou L
J Neurooncol; 2008 Sep; 89(2):121-9. PubMed ID: 18478183
[TBL] [Abstract][Full Text] [Related]
5. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
6. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W
Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438
[TBL] [Abstract][Full Text] [Related]
7. Exosomal B7-H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth.
Tian Y; Liu C; Li Z; Ai M; Wang B; Du K; Liu W; Wang H; Yu P; Chen C; Lin J; Xu A; Li R; Zhang W; Yuan Y
Redox Biol; 2022 Oct; 56():102454. PubMed ID: 36044789
[TBL] [Abstract][Full Text] [Related]
8. The B7-H4 gene induces immune escape partly via upregulating the PD-1/Stat3 pathway in non-small cell lung cancer.
Yuan L; Ye J; Fan D
Hum Immunol; 2020 May; 81(5):254-261. PubMed ID: 32113654
[TBL] [Abstract][Full Text] [Related]
9. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract][Full Text] [Related]
10. B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium.
Mo LJ; Ye HX; Mao Y; Yao Y; Zhang JM
Chin J Cancer; 2013 Dec; 32(12):653-60. PubMed ID: 23327799
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-Macrophage Colony-Stimulating Factor-Activated Neutrophils Express B7-H4 That Correlates with Gastric Cancer Progression and Poor Patient Survival.
Shan ZG; Yan ZB; Peng LS; Cheng P; Teng YS; Mao FY; Fan K; Zhuang Y; Zhao YL
J Immunol Res; 2021; 2021():6613247. PubMed ID: 33763491
[TBL] [Abstract][Full Text] [Related]
12. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.
Wei J; Wang F; Kong LY; Xu S; Doucette T; Ferguson SD; Yang Y; McEnery K; Jethwa K; Gjyshi O; Qiao W; Levine NB; Lang FF; Rao G; Fuller GN; Calin GA; Heimberger AB
Cancer Res; 2013 Jul; 73(13):3913-26. PubMed ID: 23636127
[TBL] [Abstract][Full Text] [Related]
13. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
[TBL] [Abstract][Full Text] [Related]
14. Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.
Yao Y; Luo F; Tang C; Chen D; Qin Z; Hua W; Xu M; Zhong P; Yu S; Chen D; Ding X; Zhang Y; Zheng X; Yang J; Qian J; Deng Y; Hoon DSB; Hu J; Chu Y; Zhou L
Cancer Immunol Immunother; 2018 Nov; 67(11):1777-1788. PubMed ID: 30159779
[TBL] [Abstract][Full Text] [Related]
15. B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.
Qian Y; Hong B; Shen L; Wu Z; Yao H; Zhang L
Cell Tissue Res; 2013 Jul; 353(1):139-51. PubMed ID: 23660627
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.
Lamano JB; Lamano JB; Li YD; DiDomenico JD; Choy W; Veliceasa D; Oyon DE; Fakurnejad S; Ampie L; Kesavabhotla K; Kaur R; Kaur G; Biyashev D; Unruh DJ; Horbinski CM; James CD; Parsa AT; Bloch O
Clin Cancer Res; 2019 Jun; 25(12):3643-3657. PubMed ID: 30824583
[TBL] [Abstract][Full Text] [Related]
18. Potential targeting of B7-H4 for the treatment of cancer.
Podojil JR; Miller SD
Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
[TBL] [Abstract][Full Text] [Related]
19. MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.
Wang QW; Sun LH; Zhang Y; Wang Z; Zhao Z; Wang ZL; Wang KY; Li GZ; Xu JB; Ren CY; Ma WP; Wang HJ; Li SW; Zhu YJ; Jiang T; Bao ZS
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34667077
[TBL] [Abstract][Full Text] [Related]
20. Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.
Dzaye O; Hu F; Derkow K; Haage V; Euskirchen P; Harms C; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
J Neuropathol Exp Neurol; 2016 May; 75(5):429-40. PubMed ID: 27030742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
